BFRI
Biofrontera Inc. Sets Record with Strong Q4 2025 Results, Paves Way for Future Growth
On March 19, 2026, Biofrontera Inc., a leading company in the dermatology community, announced its fourth quarter and full-year 2025 financial results, showcasing a strong performance that marks a new milestone for the company. The conference call transcript revealed that Biofrontera achieved record annual revenues of $41.7 million, representing